Cytosorbents Corp — Director's Dealing 2014

Oct 29, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cytosorbents Corp (CTSO)
CIK: 0001175151
Period of Report: 2014-10-09

Reporting Person: Chan Phillip P. (Director, President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-10-09	Common Stock	C	1061354	—	Acquired	1799376	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-10-09	Series B 10% Convertible Preferred Stock	$	C	384.21	Disposed		Common Stock (1061354)	Direct

Footnotes

F1: On October 9, 2014, upon the election of the stockholders representing over 93% of the then-issued and outstanding Series B 10% Convertible Preferred Stock, each share of Series B 10% Convertible Preferred Stock converted into that number of shares of Common Stock equal to the stated value of $100.00 at a conversion price of $0.036. The Series B 10% Convertible Preferred Stock had no expiration or exercisable date.

F2: Includes payment-in-kind dividends issued to the Reporting Person by virtue of his ownership of Series B 10% Convertible Preferred Stock prior to the conversion discussed in footnote 1 above.